Assignee
MERCK SHARP & DOHME
US·1,534 granted patents·315 pending applications·13,476 citations·filing 1973–2025
Top patents by PatentIndex Score
1,849 records- 0198US10188730B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·42 cites·41 claims
- 0298US5514718AHeterocyclic compounds, processes for their preparation and pharmaceutical compositions containing themMERCK SHARP & DOHME·Filed 1994·Granted May 7, 1996·551 cites·12 claims
- 0397US11091493B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2020·Granted Aug 17, 2021·6 cites·11 claims
- 0497US10106574B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2016·Granted Oct 23, 2018·34 cites·34 claims
- 0597US9586934B22-pyridyloxy-4-methyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·25 cites·14 claims
- 0697USD780909SAutoinjector penMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·104 cites·1 claims
- 0797US8952136B2Antibodies to human programmed death receptor PD-1MERCK SHARP & DOHME·Filed 2012·Granted Feb 10, 2015·174 cites·3 claims
- 0897US8900587B2Antibodies to human programmed death receptor PD-1MERCK SHARP & DOHME·Filed 2012·Granted Dec 2, 2014·411 cites·3 claims
- 0997US7951797B2Substituted diazepan orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted May 31, 2011·59 cites·9 claims
- 1096US11925709B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2020·Granted Mar 12, 2024·12 cites·10 claims
- 1196US11124478B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2020·Granted Sep 21, 2021·5 cites·5 claims
- 1296US10696681B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2019·Granted Jun 30, 2020·7 cites·5 claims
- 1396USD857192SAutoinjector deviceMERCK SHARP & DOHME·Filed 2016·Granted Aug 20, 2019·75 cites·1 claims
- 1496US10323090B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jun 18, 2019·26 cites·31 claims
- 1596US10189831B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·75 cites·17 claims
- 1696US10106541B2Intermediates for preparing CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2017·Granted Oct 23, 2018·16 cites·5 claims
- 1796US9833448B2Piperidinone carboxamide azaindane CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2016·Granted Dec 5, 2017·18 cites·1 claims
- 1896US9624197B22-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·24 cites·11 claims
- 1996US9617246B2Thioether-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Apr 11, 2017·18 cites·14 claims
- 2096US9556190B2Piperidinyloxy lactone orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 31, 2017·18 cites·16 claims
- 2196US9174989B2Process for making CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Nov 3, 2015·19 cites·11 claims
- 2296US7973040B2Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2009·Granted Jul 5, 2011·40 cites·12 claims
- 2396US5885999ASerine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1997·Granted Mar 23, 1999·103 cites·19 claims
- 2496US4377588A4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidaseMERCK SHARP & DOHME·Filed 1979·Granted Mar 22, 1983·37 cites·7 claims
- 2595US11767292B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted Sep 26, 2023·3 cites·12 claims
- 2695US11708371B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted Jul 25, 2023·3 cites·13 claims
- 2795US11649243B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2021·Granted May 16, 2023·3 cites·9 claims
- 2895US10899771B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2019·Granted Jan 26, 2021·7 cites·4 claims
- 2995US10577316B2Process for making beta 3 agonists and intermediatesMERCK SHARP & DOHME·Filed 2017·Granted Mar 3, 2020·9 cites·23 claims
- 3095US9850246B2Process for making CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 26, 2017·17 cites·3 claims
- 3195US9822138B2Antiviral beta-amino acid ester phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2016·Granted Nov 21, 2017·12 cites·81 claims
- 3295US9718818B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·25 cites·9 claims
- 3395US9586950B22-pyridyloxy-3-ester-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Mar 7, 2017·17 cites·12 claims
- 3495US9556145B22-pyridyloxy-4-ester orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·17 cites·15 claims
- 3595US9550786B24-fluoropiperidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 24, 2017·17 cites·12 claims
- 3695US9546152B22-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 17, 2017·17 cites·13 claims
- 3795US9499545B2Piperidinone carboxamide azaindane CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Nov 22, 2016·21 cites·3 claims
- 3895US8362212B2Engineered anti-IL-23 antibodiesMERCK SHARP & DOHME·Filed 2009·Granted Jan 29, 2013·26 cites·18 claims
- 3995US7951795B2Constrained spirocyclic compounds as CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted May 31, 2011·43 cites·12 claims
- 4095US7879815B2Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infectionMERCK SHARP & DOHME·Filed 2007·Granted Feb 1, 2011·132 cites·18 claims
- 4195US6479480B1Phenylindole derivatives as 5-ht2a receptor ligandsMERCK SHARP & DOHME·Filed 1999·Granted Nov 12, 2002·89 cites·8 claims
- 4295US6448229B2Gamma secretase inhibitorsMERCK SHARP & DOHME·Filed 2001·Granted Sep 10, 2002·54 cites·9 claims
- 4395US5614532AQuinolone derivativesMERCK SHARP & DOHME·Filed 1992·Granted Mar 25, 1997·75 cites·7 claims
- 4495US5614518AMorpholine derivatives as dopamine receptor subtype ligandsMERCK SHARP & DOHME·Filed 1994·Granted Mar 25, 1997·66 cites·9 claims
- 4595US5556969ABenzodiazepine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Sep 17, 1996·94 cites·7 claims
- 4694US10766919B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Sep 8, 2020·9 cites·15 claims
- 4794US10618958B2Anti-TIGIT antibodiesMERCK SHARP & DOHME·Filed 2017·Granted Apr 14, 2020·10 cites·32 claims
- 4894US10550190B2Phosphate based linkers for intracellular delivery of drug conjugatesMERCK SHARP & DOHME·Filed 2015·Granted Feb 4, 2020·13 cites·4 claims
- 4994USD870270SAutoinjector penMERCK SHARP & DOHME·Filed 2017·Granted Dec 17, 2019·48 cites·1 claims
- 5094US10272077B2Piperidinone carboxamide azaindane CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2017·Granted Apr 30, 2019·16 cites·19 claims
Showing the top 50 of 1,849 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →